ArticleMikrochimica acta2025
A sample-to-answer multimodal microfluidic integrated electrochemical biosensing system for rapid diagnosis of acute stroke from whole blood.
Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
A microfluidic-integrated electrochemical biosensing platform was developed, which uses two modified electrodes to separately detect two acute stroke (AS biomarkers) - homocysteine (Hcy) and adenosine (Ado) - from whole blood. The system integrates an on-chip plasma separator with multimodal electrochemical detection through rationally designed microchannels and nanostructure-based sensing interfaces. It enables the sensitive and selective quantification of Hcy and Ado in whole blood within 10 min and 40 min, respectively, with limits of detection (LOD) of 1.04 µM and 1.65 × 10⁻³ µM, respectively. The entire assay process for Ado requires a 30-minute incubation of the isolated plasma prior to differential pulse voltammetry (DPV) measurements. By performing automated sample-to-answer analysis, this platform provides a reliable method for the detection of AS-related biomarkers. Furthermore, the integration of on-chip blood processing with electrochemical detection presents a promising approach for future point-of-care and emergency diagnostic applications.
Indexed as
Identifiers
41240195What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.